C.S. Azad, A.K. Saxena / Tetrahedron 69 (2013) 2608e2612
2611
combined organic layer repeatedly washed with water to remove
DMF, then dried over Na2SO4 and dried under vacuum to dryness.
Third approach: Alcohol (1.5 mmol) was taken in 50 ml RB flask
and 5 ml pyridine, 1 ml hexamethyldisilazane and 0.5 ml of tri-
methylsilyl chloride (TMSCl) is added consecutively, and stirred for
45 min at room temperature followed by the evaporation to the
dryness. The residue so left was dissolved in 10 ml of dichloro-
methane and 2.5 ml of tetrabutyl ammonium fluoride (TBAF) in THF
(1 M) and BtSO2Bt (1.5 mmol) added consecutively. The reaction
mixture was refluxed under nitrogen atmosphere for about 5 h and
then diluted with DCM, washed with water, dried over Na2SO4 and
evaporated under vacuum to dryness.
using first approach is purified using column chromatography
(5e10% EtOAc/hexane) to give the title compound (0.470 g, 90%) as
ꢀ
20
an oil; [
a
]
C þ4.2 (c 0.3, CHCl3); IR (nmax, Neat, cmꢁ1): 1590, 1465,
D
1360, 1250, 785; 1H NMR (300 MHz, CDCl3) : dH 7.58e6.97 (m, 10H),
5.69 (s, 1H), 5.02 (d, J¼11.9 Hz, 1H), 4.90 (d, J¼12.1 Hz, 1H), 4.79 (s,
1H), 4.45 (d, J¼10.3 Hz, 1H), 4.34 (d, J¼8.0 Hz, 2H), 4.08e3.74 (m,
3H), 3.39 (s, 3H). 13C NMR (75 MHz, CDCl3): dC 138.91, 138.03,
129.24, 128.48, 128.30, 128.18, 127.51, 126.02, 102.08, 95.90, 79.14,
75.77, 73.72, 67.01, 60.80, 59.57, 55.32; Anal. Calcd for C21H23ClO5
(390.12): 64.53; H, 5.93%, Found: C, 64.47; H, 5.2.79. ES-MS (MþHþ)
391.1 m/z.
3.2.6. Methyl 3-O-benzyl-4,6-O-benzylidene-3-chloro-3-deoxy-a-D-
3.2.1. 3-Chloro(R)-3-deoxy-1,2:5,6-di-O-isoproplylidene-
anose (1b). The crude product obtained from 1 g 1a using first
approach was purified using column chromatography (5% EtOAc/
a
-
D
-allofur-
altroside (6b). The crude product obtained from 1.0 g 6a using first
approach was purified using column chromatography (15% EtOAc/
hexane) to give the title compound (0.92 g, 88%) as off white solid;
20 ꢀC
hexane) to give the title compound (1.01 g, 95%) as off white solid;
mp 83e84 ꢀC (from hexane); [
a
]
þ188 (c 0.5, CHCl3); IR (nmax
,
D
20 ꢀC
mp 53e54 ꢀC (from hexane); [
a
]
þ42 (c 0.5, CHCl3); IR (nmax
,
Neat, cmꢁ1): 1465, 1397, 1210, 715; 1H NMR (300 MHz, CDCl3)
:7.8e7.1 (m, 10H), 5.77 (s, 1H), 4.95e4.84 (m, 2H), 4.65 (m, 1H), 4.43
(m, 1H), 4.22 (m, 1H), 3.8e4.18 (m, 4H), 3.40 (s, 3H); 13C NMR
D
Neat, cmꢁ1): 1435, 1373, 1150, 740; 1H NMR (300 MHz, CDCl3):
6.01 (d, J¼3.6 Hz, 1H), 5.42e5.21 (m, 1H), 4.92 (d, J¼3.7 Hz, 1H),
4.40e4.20 (m, 2H), 4.16 (m, 1H), 4.10e3.93 (m, 1H), 1.47e1.24 (m,
12H); 13C NMR (75 MHz, CDCl3):
113.03, 107.52, 101.05, 81.27,
d
(75 MHz, CDCl3):
d 137.17, 136.83, 129.04, 128.57, 128.18, 127.79,
d
126.37, 101.86, 98.86, 77.87, 76.32, 73.58, 67.85, 66.33, 63.22, 55.08;
Elemental Anal. for C21H23ClO5 (390.12) Calcd C, 64.53; H, 5.93%,
Found: C, 64.21; H, 5.84. ES-MS (MþHþ) 391.1 m/z.
79.93, 72.90, 69.23 63.93, 27.43, 26.61, 25.43, 24.94; Anal. Calcd for
C12H19ClO5 (278.09): C, 51.71; H, 6.87%, Found: C, 51.63; H, 5.79. ES-
MS (MþHþ) 279.1 m/z.
3.2.7. Methyl 4,6-O-benzylidene-2-benzyloxycarbonylamino-2,3-
3.2.2. 3-Chloro(S)-3-deoxy-1,2:5,6-di-O-isoproplylidene-
a-
D
-allofur-
dideoxy-3-ioso-a-D-allopyranoside (7b). The crude product ob-
anose (2b). The crude product obtained from 1 g 2a using first ap-
proach was purified using column chromatography (5% EtOAc/
tained from 0.5 g of 7a using first approach was purified using col-
umn chromatography (30% EtOAc/hexane) to give the title
hexane) to give the title compound (1.01 g, 96%) as off white solid;
compound (0.480 g, 92%) as an off white solid; mp 99e102 ꢀC (from
20 ꢀC
20 ꢀC
mp 63e64 ꢀC (from hexane); [
a
]
D
ꢁ39 (c 0.5, CHCl3); IR (nmax
,
ethanol); [
a
]
D
e19.5 (c 0.7, CHCl3); IR (nmax, Neat, cmꢁ1):1585,
Neat, cmꢁ1): 1432,1369,1148, 739; 1H NMR (300 MHz, CDCl3):
d
5.99
1456, 1345, 950, 815, 785; 1H NMR (300 MHz, CDCl3):
d 7.58e7.42
(d, J¼3.7 Hz, 1H), 4.95e5.01 (m, 1H), 4.46e4.40 (m, 3H), 4.40e4.38
(m, 2H), 7.26 (d, J¼23.4 Hz, 8H), 5.77 (s, 1H), 5.06 (d, J¼14.3 Hz, 3H),
(m, 1H), 4.24e4.20 (m, 1H), 1.79e1.57 (m, 12H); 13C NMR (75 MHz,
4.81 (s, 1H), 4.52e4.17 (m, 1H), 4.17e3.85 (m, 1H), 3.36 (s, 3H); 13C
CDCl3):
d
113.01, 107.53, 105.57, 81.26, 79.93, 72.88, 69.23, 63.93,
NMR (75 MHz, CDCl3): d 155.96, 136.74, 129.06, 128.68, 128.20,
27.42, 26.59, 25.14, 24.94; Anal. Calcd for C12H19ClO5 (278.09): C,
128.04,126.37,103.87,101.99, 76.62, 68.92, 67.42, 66.95, 60.60, 57.78,
55.29; Anal. Calcd for C22H24ClNO6 (433.88): C, 60.90; H, 5.58; N,
3.23%. Found: C, 60.53; H, 5.18; N, 3.14. ES-MS (MþHþ) 434.9 m/z.
51.71; H, 6.87%, Found: C, 51.64; H, 5.76. ES-MS (MþHþ) 279.1 m/z.
3.2.3. 6-Chloro-6-deoxy-1,2:3,4-di-O-isopropylidine-a-galactopyr-
anose (3b). The crude product obtained from 1.0 g 3a using first
approach was purified using column chromatography (5% EtOAc/
Acknowledgements
hexane) to give the title compound (1.0 g, 93%) as off white solid;
20 ꢀC
C.S.A. is thankful to CSIR, New Delhi for the award of SRF and
acknowledges, A.S. Kushwaha, Mr. Zahid Ali for their technical
support. The authors also acknowledge SAIF-CDRI for providing
spectral and analytical data. The CDRI communication number al-
lotted to this manuscript is 8391.
mp 43e44 ꢀC (from hexane); [
a
]
ꢁ58 (c 0.5, CHCl3); IR (nmax
,
D
Neat, cmꢁ1): 1440, 1370, 1120, 735; 1H NMR (300 MHz, CDCl3):
5.55 (d, J¼5.0 Hz, 1H), 4.72e4.52 (m, 3H), 4.37 (dd, J¼5.0, 2.6 Hz,
1H), 4.32e4.12 (m, 2H), 1.54 (s, 3H), 1.47 (s, 3H), 1.35 (s, 6H); 13C
NMR (75 MHz, CDCl3): 101.58, 108.29, 100.47, 75.48, 75.21, 73.28,
d
d
69.82, 68.48, 44.04, 27.49, 27.26, 26.08, 25.94; Elemental Anal. for
C12H19ClO5 (278.09) Calcd C, 51.71; H, 6.87%, Found: C, 51.65; H,
5.69. ES-MS (MþHþ) 279.1 m/z.
Supplementary data
Supplementary data related to this article can be found online at
3.2.4. 1,2-O-Isopropylidene-3-O-benzyl-5-deoxy-5-iodo-a-D-xylofur-
anose (4b). The crude product obtained from 1.0 g 4a using first
approach was purified using column chromatography (15% EtOAc/
References and notes
hexane) to give the title compound (0.97 g, 92%) as off white solid;
20 ꢀC
mp 73e74 ꢀC (from hexane); [
a]
ꢁ39 (c 0.5, CHCl3); IR (nmax
,
1. (a) Grotz, V. L.; Henry, R. R.; McGill, J. B.; Prince, M. J.; Shamoon, H.; Trout, J. R.; Pi-
Sunyer. J. Am. Diet. Assoc. 2003, 103, 1607; (b) Ford, H. E.; Peters, V.; Martin, N. M.;
Sleeth, M. L.; Ghatei, M. A.; Frost, G. S.; Bloom, S. R. Eur. J. Clin. Nutr. 2011, 65, 508.
2. (a) Ford, W. C. L.; Waites, G. M. H. Int. J. Androl. 1978, 1, 541; (b) Hinton, B. T.;
Hernandez, H.; Howards, S. S. J. Androl. 1983, 4, 216.
3. Thomas, S. S.; Plenkiewicz, J.; Ison, E. R.; Bols, M.; Zou, W.; Szarek, W. A.; Ki-
silevsky, R. Biochim. Biophys. Acta 1995, 1272, 37.
4. (a) Birkenmeyer, R. D.; Kagan, F. J. Med. Chem. 1970, 13, 616; (b) Tsuchiya, T.;
Umezawa, S. Bull. Chem. Soc. Jpn. 1965, 38, 1181.
5. (a) Jenkins, I. D.; Verheyden, J. P. H.; Moffatt, J. G. J. Am. Chem. Soc. 1971, 93,
4323; (b) Egli, M.; Pallan, P. S.; Allerson, C. R.; Prakash, T. P.; Berdeja, A.; Yu, J.;
Lee, S.; Watt, A.; Gaus, H.; Bhat, B.; Swayze, E. E.; Seth, P. P. J. Am. Chem. Soc.
2011, 133, 16642; (c) Wnuk, S. F.; Robert, J.; Sobczak, A. J.; Meyers, B. P.; Malladi,
V. L. A.; Zhu, J.; Gopishetty, B.; Pei, D. Bioorg. Med. Chem. 2009, 17, 6699; (d)
D
Neat, cmꢁ1): 1430, 1363, 1114, 890, 732; 1H NMR (300 MHz, CDCl3) :
7.45e7.12 (m, 5H), 5.58 (1H), 4.75e4.55 (m, 3H), 4.28 (m, 1H),
3.78, (1H), 3.55e3.72 (m, 2H), 1.48 (3H), 1.31 (3H); 13C NMR
(75 MHz, CDCl3): 137.56, 128.30, 127.80, 127.74, 111.9, 81.75, 80.16,
d
d
79.32, 71.36, 39.60, 26.34, 25.81; Elemental. Anal. for C15H19ClO4
(298.10) Calcd C, 60.30; H, 6.41%, Found: C, 59.98; H, 6.31. ES-MS
(MþHþ) 299.1 m/z.
3.2.5. Methyl 3-O-benzyl-4,6-O-benzylidene-2-chloro-2-deoxy-
a-D-
mannopyranoside (5b). The crude product obtained from 0.5 g 5a